Shu Uin Gan

Gan Shu Uin

  • Senior Research Fellow, Department of Surgery
Academic Qualifications
  • PhD, King’s College London, United Kingdom
  • BSc, National University of Singapore, Singapore
Research Interest(s)
  • Adeno-associated Virus
  • Lentiviral Vectors
  • Gene Therapy
  • Cell Therapy
Recent Publications
  • 1. Fong CY, Tam K, Cheyyatraivendran S, Gan SU, Gauthaman K, Arunmozhiarasi, Jeyaseelan K, Choolani M, Biswas A, Bongso A. 2017 Sep. Human Wharton's Jelly Stem Cells and Its Conditioned Medium Enhance Healing of Excisional and Diabetic Wounds. Journal of Cellular Biochemistry. 118(9):3016. doi:10.1002/jcb.26081.
  • 2. Kizilors A, Pickard MR, Schulte CE, Yacqub-Usman K, McCarthy NJ, Gan S-U, Darling D, Gaken J, Williams GT, Farzaneh F. 2017 Aug. Retroviral insertional mutagenesis implicates E3 ubiquitin ligase RNF168 in the control of cell proliferation and survival. Bioscience Reports. 37: BSR20170843. doi: 10.1042/BSR20170843.
  • 3. Gautam P, Recino A, Foale RD, Zhao J, Gan SU, Wallberg M, Calne R, Lever AML. 2016 Oct. Promoter optimisation of lentiviral vectors for efficient insulin gene expression in canine mesenchymal stromal cells: potential surrogate beta cells. Journal of Gene Medicine. 18(10):312-321. doi: 10.1002/jgm.2900.
  • 4. Uin GS, Maria N, Ying FZ, Onn LK, Chuan SK, Chunilal NA, Marco DP, Yorke CR. 2016 Feb. Correction of murine diabetic hyperglycaemia with a single systemic administration of an AAV2/8 vector containing a novel codon optimized human insulin gene. Current Gene Therapy. 16(1):65-72. doi: 10.2174/1566523216666160122113958.